Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11065240 Drug combinations to treat multiple myeloma

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
August 5, 2015
Date of Patent
July 20, 2021
Patent Applicant
Exelixis
Exelixis
Patent Application Number
15501582
Patent Citations
‌
US Patent 10166225 Method for treating osteoporosis
‌
US Patent 10034873 C-met modulator pharmaceutical compositions
‌
US Patent 10039757 C-Met modulator pharmaceutical compositions
‌
US Patent 10159666 Dosing of cabozantinib formulations
‌
US Patent 10273211 Metabolites of N-{4-([6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
Patent Citations Received
‌
US Patent 12064430 Kinase inhibitor salts and compositions thereof
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11065240
Patent Primary Examiner
‌
D Margaret M Seaman

Find more entities like US Patent 11065240 Drug combinations to treat multiple myeloma

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo